F-3 F-3 EX-FILING FEES 0000888721 TRINITY BIOTECH PLC N/A Y N 0000888721 2026-05-11 2026-05-11 0000888721 1 2026-05-11 2026-05-11 0000888721 1 2026-05-11 2026-05-11 0000888721 2 2026-05-11 2026-05-11 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

F-3

TRINITY BIOTECH PLC

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Ordinary shares, par value $0.0001 per share Other 3,359,022,000 $ 0.03086 $ 103,659,418.92 0.0001381 $ 14,315.37
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 103,659,418.92

$ 14,315.37

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 5,402.97

Net Fee Due:

$ 8,912.40

Offering Note

1

a. The Ordinary Shares registered hereby are evidenced by American Depositary Shares ("ADSs"). ADSs (evidenced by American Depositary Receipts, each representing 20 Ordinary Shares, par value $0.0001 per share), have been registered on separate registration statements on Form F-6 filed on January 27, 2026 (File No. 333-292980). b. Represents (i) 2,865,046,434 Ordinary Shares represented by 143,252,322 ADSs that may be acquired by a selling shareholder upon conversion of a convertible note and (ii) 493,973,523 Ordinary Shares represented by 24,698,676 ADSs that may be acquired by a selling shareholder pursuant to a conversion rights agreement entered into on December 22, 2025 (collectively, the "Conversion Shares"). c. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(a) under the Securities Act of 1933, as amended, based on the average of the high and low sales prices of the registrant's ADSs on Nasdaq on May 8, 2026, in accordance with Rule 457(c) under the Securities Act of 1933, as amended. The Ordinary Shares registered hereby are evidenced by ADSs, and the proposed maximum offering price per Ordinary Share has been derived by dividing the ADS market price by 20, because each ADS represents 20 Ordinary Shares. No additional consideration is payable upon conversion of the Conversion Shares by the selling shareholders. d. This registration statement was initially filed with the Securities and Exchange Commissions on January 15, 2026 as a Registration Statement on Form F-1 (File No. 333-292753)(the "Prior Registration Statement") to register the Conversion Shares, at which time a filing fee of $5,402.97, computed in accordance with Rule 457 under the Securities Act, was paid. The Registrant has terminated or completed any offerings that included the unsold securities under the Prior Registration Statement. e. The registration statement also includes an indeterminate number of Ordinary Shares underlying the ADSs that may become issuable to prevent dilution resulting from stock splits, stock dividends and similar transactions, which are included pursuant to Rule 416 under the Securities Act of 1933, as amended.

Table 2: Fee Offset Claims and Sources ☐Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims
Fee Offset Sources
Rule 457(p)
Fee Offset Claims 1 TRINITY BIOTECH PLC F-1 333-292753 01/15/2026 $ 5,402.97 Equity Ordinary shares, par value $0.0001 per share 1,117,818,000 $ 39,123,630.00
Fee Offset Sources TRINITY BIOTECH PLC F-1 333-292753 01/15/2026 $ 5,402.97

Rule 457(p) Statement of Withdrawal, Termination, or Completion:

1

The Registrant has terminated or completed any offerings that included the unsold securities under the Prior Registration Statement.

Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date